Consumers  |  For Healthcare Professionals Only

  • slider image 1
  • slider image 2
  • slider image 3
  • slider image 4

Naus-Ease® Products

image 1

Naus-Ease® Tablets

A prescription quality tablet, that is now available over the counter (non-prescription) for adults and children 12 years of age and over to help prevent and treat nausea and vomiting for up to 24 hours with just one dose. OTC Naus-Ease® Tablets are currently the only prescription quality drug available over the counter for the prevention and treatment of nausea and vomiting. Rest assured that your patients are getting the quality they deserve.

Learn more
image 2

Naus-Ease® Film Strips

As healthcare professionals we are aware that recommending any medicine, especially OTC drugs, is more than simply selecting the right brand. Often times we take in account for dietary restrictions or other factors including an individuals occupation. Naus-Ease® Film Strips were developed as a convenient way to carry medicine, as well as a much simpler way to take medicine while conforming to the patient’s individual needs.

Learn more
image 3

Children's Naus-Ease®

Available Soon!

image 4

Quality Guaranteed!

Naus-Ease® products were developed with one goal in mind, which was to not only meet but exceed the United States Food and Drug Administration's (FDA) requirements in terms of product quality. Naus-Ease® products are developed and manufactured in the United States of America under full scrutiny of the FDA, and in full compliance of all applicable laws, regulations, and standards.

Frequently Asked Questions

FAQ image 1

How long does it take for Naus-Ease® Film Strips to dissolve on the tongue?

Naus-Ease® Film Strips are designed to begin dissolving upon contact with a wet surface, such as the saliva on the tongue. Although the dissolution time varies from one patient to another, Naus-Ease® Film Strips generally dissolve within a few seconds, typically under 30 seconds. This allows the patient / consumer to take their medicine without need for additional liquid or fear of choking on a tablet.

FAQ image 2

Should Naus-Ease® be taken with food or can it be taken on an empty stomach?

Naus-Ease® Tablets or Naus-Ease® Film Strips can be taken either with food or on an empty stomach.

FAQ image 3

What are the most common side effects of Naus-Ease®?

The side effects from taking Naus-Ease® Tablets or Naus-Ease® Film Strips are typically considered minor. Although Meclizine HCl, the active ingredient in both Naus-Ease® Tablets and Naus-Ease® Film Strips, is known to be a less drowsy antiemetic, the most common reported side effects are drowsiness and/or dry mouth.

FAQ image 4

Can Naus-Ease® be used for reasons other than Vertigo or Motion Sickness?

Naus-Ease® has been the tried and true product for the prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness, as well as the treatment of vertigo. Furthermore, Naus-Ease® is an antiemetic - an agent that prevents or treats nausea and vomiting. However, as healthcare professionals, we strongly urge you to evaluate and properly diagnose the patient ensuring that their nausea and / or vomiting is not a result of any other potentially severe illness.

Contact Us

Thank you for your interest in Naus-Ease® products, developed, marketed, and managed by Sunascen Therapeutics LLC. This Website is intended to provide healthcare professionals with information and in response to unsolicited questions regarding Naus-Ease® products. Do you have questions or comments for us? Please feel free to contact us via the contact information below and one of our professionals will be happy to reply as soon as possible. If you send us an email, please note that every attempt will be made to respond to inquiries within three to five business days.


  Product Related Inquiries

A qualified member of our staff will be happy to answer any product-related questions you may have regarding Naus-Ease® products. If you wish to report an adverse event or product complaint regarding a Naus-Ease® product, you may do so by mailing us the details, only to the postal mailing address OR the appropriate email address identified below. Please note that the information on this website is provided as a professional courtesy for informational and general educational purposes only. The information is not intended to provide the healthcare professional with advice in respect to specific treatments for a particular patient. It is solely intended to provide you, the healthcare professional, with information to assist you in forming your own conclusions and making appropriate clinical decisions. The responsibility for patient care resides with the healthcare professional using his or her professional training, experience, and knowledge of the patient and their medical history to determine the appropriateness, correct dosage, and delivery of drug therapy. Before prescribing or recommending any over the counter product developed or marketing by Sunascen Therapeutics, please read the full prescribing information or relevant labeling documents. Sunascen Therapeutics does not recommend the use of Sunascen Therapeutics products in any manner other than what is described in the full prescribing information or product labeling documents for over the counter products. The information provided on this website is intended solely for use by healthcare professionals practicing in the United States of America. The dissemination of this product or medical information may be subject to different medical and/or regulatory requirements in other countries.



Sales Related Inquiries
For product sales related inquiries please send an email to Sales@sunascen.com.

Information Requests from Healthcare Professionals
If you are a healthcare professional and have questions, concerns, or would like other medical information regarding a Naus-Ease® product, you may send an email to MedInfo@sunascen.com. Our professional staff will be glad to assist you. If you would like us to call you in return, simply note that in your email along with your telephone number and the best time to contact you. We will make every attempt to respond to your emails or return your call as soon as possible.

Report an Adverse Event or Product Complaint
To report an adverse event or a product complaint for a Naus-Ease® product, you may send an informative email to Pharmacovigilance@sunascen.com. Be sure to include your (reporting healthcare professional) information along with the patients information, and the details of the adverse event or product complaint.

You may also contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch. This service allows health care professionals and consumers to report serious problems they suspect may be associated with the drugs and medical devices they dispense, prescribe, or have used. To report a serious problem visit FDA’s MedWatch, or by calling 1-800-FDA-1088.

Postal Mail
If you prefer to correspond with us via regular mail, please use the address listed below.


Sunascen Therapeutics LLC
PO BOX 2773
Wilmington DE 19805


Sunascen Therapeutics LLC

NAUS-EASE® Tablets

As a healthcare professional, your patients expect and trust that you will recommend what is best for their health needs. When recommending Naus-Ease® Tablets, you can be fully confident that your patients are going to receive the best quality product available over the counter for the prevention and treatment of nausea and vomiting.

Naus-Ease® (Meclizine HCl) Tablets are currently the ONLY prescription quality drug available over the counter for the prevention and treatment of nausea and vomiting.

Naus-Ease® Tablets
Product Information & Drug Facts

Active Ingredients
In each tablet: Meclizine Hydrochloride, USP 25 mg

Purposes
Antiemetic

Indications and Usage
For Consumers (the general public):
Naus-Ease® (Meclizine Hydrochloride), USP Tablets are used for the prevention and treatment of nausea and vomiting, or dizziness associated with motion sickness.

For Health Professionals:
Based on a review of Meclizine Hydrochloride, USP drug by the National Academy of Sciences – National Research Council and/or other information, FDA has classified the indications of Meclizine Hydrochloride, USP as follows:
  1. The prevention and treatment (management) of nausea and vomiting, and dizziness associated with motion sickness.
  2. For the treatment of vertigo.

Description
Chemically, Meclizine Hydrochloride, USP is 1-(p-Chloro-α-phenylbenzyl)-4-(m-methylbenzyl) piperazine dihydrochloride monohydrate. Meclizine Hydrochloride, USP is an oral antiemetic, which is a white to slightly yellowish crystalline powder having a slight odor and is tasteless. The molecular weight is 481.88544 g/mol. It has the following structural formula:
Meclizine Chemical Structure
C25H27CIN2·2HCl·H20

Clinical Pharmacology
Meclizine Hydrochloride, USP is an antihistamine that shows marked protective activity against nebulized histamine and lethal doses of intravenously injected histamine in guinea pigs. It has a marked effect in blocking the vasodepressor response to histamine, but only a slight blocking action against acetylcholine. Its activity is relatively weak in inhibiting the spasmogenic action of histamine on isolated guinea pig ileum.

Pharmacokinetics
The available pharmacokinetic information for Meclizine Hydrochloride, USP following oral administration has been summarized from published literature.

Absorption
Meclizine Hydrochloride, USP is absorbed after oral administration with maximum plasma concentrations reaching at a median Tmax value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.

Distribution
Drug distribution characteristics for Meclizine Hydrochloride, USP in humans remains unknown.

Metabolism
The metabolic fate of Meclizine Hydrochloride, USP in humans is unknown. In an in vitro metabolic study using human hepatic microsome and recombinant CYP enzyme, CYP 2D6 was found to be the dominant enzyme for metabolism of Meclizine Hydrochloride, USP.
The genetic polymorphism of CYP2D6 that results in extensive-, poor-, intermediate- and ultrarapid metabolizer phenotypes could contribute to large inter-individual variability in Meclizine Hydrochloride, USP exposure.

Elimination
Meclizine Hydrochloride, USP has a plasma elimination half-life of about 5-6 hours in humans.

Contraindications
Meclizine Hydrochloride, USP is contraindicated in individuals who have shown a previous hypersensitivity to it.

Warnings
Clinical studies establishing safety and effectiveness in children under 12 years of age have not been done; therefore, usage is not recommended in children under 12 years of age unless directed by a doctor.

Due to its potential anticholinergic action, do not take unless directed by a doctor if you have a breathing problem such as asthma, emphysema, or chronic bronchitis, glaucoma, or difficulty in urination due to enlargement of the prostate gland.

Ask a doctor before use if you are taking sedatives or tranquilizers.

When using this product:
1. Do not exceed the recommended dosage.
2. May cause drowsiness.
3. Patients should avoid alcoholic beverages while taking this drug.
4. Since drowsiness may, on occasion, occur with use of this drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery. Therefore patients are reminded caution when driving or operating machinery.
5. Alcohol, sedatives and tranquilizers may increase drowsiness.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, seek medical help or contact a Poison Control Center right away.
Call Poison Control at 1-800-222-1222

Precautions
Pediatric Use
Clinical studies establishing safety and effectiveness in children under 12 years of age have not been done; therefore, usage is not recommended in children under 12 years of age unless directed by a doctor.

Pregnancy Use
Pregnancy Category B. Reproduction studies in rats have shown cleft palates at 25 to 50 times the human dose. Epidemiological studies in pregnant women, however, do not indicate that Meclizine Hydrochloride, USP increases the risk of abnormalities when administered during pregnancy. Despite the animal findings, it would appear that the possibility of fetal harm is remote. Nevertheless, Meclizine Hydrochloride, USP or any other medication, should be used during pregnancy only if clearly necessary, and after speaking with a health professional.

Nursing Mothers
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Meclizine Hydrochloride, USP is administered to a nursing woman.

Hepatic Impairment
The effect of hepatic impairment on the pharmacokinetics of meclizine has not been evaluated. As Meclizine Hydrochloride, USP undergoes metabolism, hepatic impairment may result in increased systemic exposure of the drug. Treatment with Meclizine Hydrochloride, USP should be administered with caution in patients with hepatic impairment.

Renal Impairment
The effect of renal impairment on the pharmacokinetics of Meclizine Hydrochloride, USP has not been evaluated. Due to a potential for drug/metabolite accumulation, Meclizine Hydrochloride, USP should be administered with caution in patients with renal impairment and in the elderly as renal function generally declines with age.

Drug Interactions
Based on in vitro evaluation, Meclizine Hydrochloride, USP is metabolized by CYP2D6. Therefore there is a possibility for a drug interaction between Meclizine Hydrochloride, USP and CYP2D6 inhibitors. Additionally, there may be increased CNS depression when Meclizine Hydrochloride, USP is administered concurrently with other CNS depressants, including alcohol, tranquilizers and sedatives. (see Warnings)

Adverse Reactions
Anaphylactoid reaction, drowsiness, dry mouth, headache, fatigue, vomiting and, on rare occasions, blurred vision have been reported.

Dosage and Administration (Directions)
Adults and children 12 years of age and over: Take 1 to 2 Naus-Ease® (Meclizine Hydrochloride), USP Tablets (25 mg to 50 mg) by mouth once daily, or as directed by a physician.

The initial dose of 25 mg to 50 mg of Naus-Ease® (Meclizine Hydrochloride), USP Tablets should be taken one hour prior to travel for the prevention and treatment of motion sickness. Thereafter, the dose may be repeated every 24 hours for the duration of the journey.

Inactive Ingredients
Each tablet contains the following inactive ingredients: Colloidal Silicon Dioxide, Croscarmellose Sodium, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose, D&C Yellow #10, Aluminum Lake.

How It's Supplied, and Other Useful Information
Naus-Ease® (Meclizine Hydrochloride), USP Tablets are available in 25mg strengths, and is available in an 8 and 16 count package size.

NDC Numbers:
Naus-Ease® (Meclizine Hydrochloride), USP;   8 Tablets: 49467-124-08
Naus-Ease® (Meclizine Hydrochloride), USP; 16 Tablets: 49467-124-16

Tamper Evident: Do not use if carton is opened or if blister unit is torn, broken or shows any signs of tampering.

Note:
Store at controlled room temperature 68° - 77° F (20° - 25° C)
Protect from heat and humidity
The lot number and expiration date appear on the side panel of each carton


NAUS-EASE® Film Strips

Whether the individual asking for your medical advice is a jet setting professional, the florist around the corner or simply someone who is always on the go, breaking away from their activities or plans to purchase the right drug can be more than just inconvenient. More often then not, individuals who take any medicine don’t feel comfortable divulging their medicinal needs in public settings either. Naus-Ease® Film Strips were developed as a convenient way to carry medicine, as well as a much simpler way to take medicine while conforming to possible dietary restrictions. Below are a few more reasons why Naus-Ease® Film Strips might be the right choice for your patients.

       ~Discreet: Each Naus-Ease® Film Strip is individually wrapped in a pouch smaller than the size of a business card. That’s right; you can carry it with you anywhere you go!
       ~Fast Melting: Dissolves on top of the tongue within seconds
       ~Easy to Administer: No need to swallow a tablet and no gritty after taste from chewable tablets
       ~Airplane Friendly: No messy syrups or bottles of water to carry
       ~Taste: A pleasant lime flavor
       ~Dietary Restriction Friendly:
              +Does not contain lactose
              +Does not contain gluten
              +Does not contain sugar

Naus-Ease® Film Strips
Product Information & Drug Facts

Active Ingredients
In each film strip: Meclizine Hydrochloride, USP 25 mg

Purposes
Antiemetic

Indications and Usage
For Consumers (the general public):
Naus-Ease® (Meclizine Hydrochloride), USP Film Strips are used for the prevention and treatment of nausea and vomiting, or dizziness associated with motion sickness.

For Health Professionals:
Based on a review of Meclizine Hydrochloride, USP drug by the National Academy of Sciences – National Research Council and/or other information, FDA has classified the indications of Meclizine Hydrochloride, USP as follows:
  1. The prevention and treatment (management) of nausea and vomiting, and dizziness associated with motion sickness.
  2. For the treatment of vertigo.

Description
Chemically, Meclizine Hydrochloride, USP is 1-(p-Chloro-α-phenylbenzyl)-4-(m-methylbenzyl) piperazine dihydrochloride monohydrate. Meclizine Hydrochloride, USP is an oral antiemetic, which is a white to slightly yellowish crystalline powder having a slight odor and is tasteless. The molecular weight is 481.88544 g/mol. It has the following structural formula:
Meclizine Chemical Structure
C25H27CIN2·2HCl·H20

Clinical Pharmacology
Meclizine Hydrochloride, USP is an antihistamine that shows marked protective activity against nebulized histamine and lethal doses of intravenously injected histamine in guinea pigs. It has a marked effect in blocking the vasodepressor response to histamine, but only a slight blocking action against acetylcholine. Its activity is relatively weak in inhibiting the spasmogenic action of histamine on isolated guinea pig ileum.

Pharmacokinetics
The available pharmacokinetic information for Meclizine Hydrochloride, USP following oral administration has been summarized from published literature.

Absorption
Meclizine Hydrochloride, USP is absorbed after oral administration with maximum plasma concentrations reaching at a median Tmax value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.

Distribution
Drug distribution characteristics for Meclizine Hydrochloride, USP in humans remains unknown.

Metabolism
The metabolic fate of Meclizine Hydrochloride, USP in humans is unknown. In an in vitro metabolic study using human hepatic microsome and recombinant CYP enzyme, CYP 2D6 was found to be the dominant enzyme for metabolism of Meclizine Hydrochloride, USP.
The genetic polymorphism of CYP2D6 that results in extensive-, poor-, intermediate- and ultrarapid metabolizer phenotypes could contribute to large inter-individual variability in Meclizine Hydrochloride, USP exposure.

Elimination
Meclizine Hydrochloride, USP has a plasma elimination half-life of about 5-6 hours in humans.

Contraindications
Meclizine Hydrochloride, USP is contraindicated in individuals who have shown a previous hypersensitivity to it.

Warnings
Clinical studies establishing safety and effectiveness in children under 12 years of age have not been done; therefore, usage is not recommended in children under 12 years of age unless directed by a doctor.

Due to its potential anticholinergic action, do not take unless directed by a doctor if you have a breathing problem such as asthma, emphysema, or chronic bronchitis, glaucoma, or difficulty in urination due to enlargement of the prostate gland.

Ask a doctor before use if you are taking sedatives or tranquilizers.

When using this product:
1. Do not exceed the recommended dosage.
2. May cause drowsiness.
3. Patients should avoid alcoholic beverages while taking this drug.
4. Since drowsiness may, on occasion, occur with use of this drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery. Therefore patients are reminded caution when driving or operating machinery.
5. Alcohol, sedatives and tranquilizers may increase drowsiness.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, seek medical help or contact a Poison Control Center right away.
Call Poison Control at 1-800-222-1222

Precautions
Pediatric Use
Clinical studies establishing safety and effectiveness in children under 12 years of age have not been done; therefore, usage is not recommended in children under 12 years of age unless directed by a doctor.

Pregnancy Use
Pregnancy Category B. Reproduction studies in rats have shown cleft palates at 25 to 50 times the human dose. Epidemiological studies in pregnant women, however, do not indicate that Meclizine Hydrochloride, USP increases the risk of abnormalities when administered during pregnancy. Despite the animal findings, it would appear that the possibility of fetal harm is remote. Nevertheless, Meclizine Hydrochloride, USP or any other medication, should be used during pregnancy only if clearly necessary, and after speaking with a health professional.

Nursing Mothers
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Meclizine Hydrochloride, USP is administered to a nursing woman.

Hepatic Impairment
The effect of hepatic impairment on the pharmacokinetics of meclizine has not been evaluated. As Meclizine Hydrochloride, USP undergoes metabolism, hepatic impairment may result in increased systemic exposure of the drug. Treatment with Meclizine Hydrochloride, USP should be administered with caution in patients with hepatic impairment.

Renal Impairment
The effect of renal impairment on the pharmacokinetics of Meclizine Hydrochloride, USP has not been evaluated. Due to a potential for drug/metabolite accumulation, Meclizine Hydrochloride, USP should be administered with caution in patients with renal impairment and in the elderly as renal function generally declines with age.

Drug Interactions
Based on in vitro evaluation, Meclizine Hydrochloride, USP is metabolized by CYP2D6. Therefore there is a possibility for a drug interaction between Meclizine Hydrochloride, USP and CYP2D6 inhibitors. Additionally, there may be increased CNS depression when Meclizine Hydrochloride, USP is administered concurrently with other CNS depressants, including alcohol, tranquilizers and sedatives. (see Warnings)

Adverse Reactions
Anaphylactoid reaction, drowsiness, dry mouth, headache, fatigue, vomiting and, on rare occasions, blurred vision have been reported.

Dosage and Administration (Directions)
Adults and children 12 years of age and over: Take 1 to 2 Naus-Ease® (Meclizine Hydrochloride), USP Film Strips (25 mg to 50 mg) once daily, or as directed by a physician. Place a film strip on the tongue. Allow each film strip to completely dissolve, and then swallow.

The initial dose of 25 mg to 50 mg of Naus-Ease® (Meclizine Hydrochloride), USP Film Strips should be taken one hour prior to travel for the prevention and treatment of motion sickness. Thereafter, the dose may be repeated every 24 hours for the duration of the journey.

Inactive Ingredients
Polyethylene oxide, Hydroxypropyl methylcellulose, Maltitol, Citric acid, Sodium citrate, and FD&C green #3

How It's Supplied, and Other Useful Information
Naus-Ease® (Meclizine Hydrochloride), USP Film Strips are available in 25mg strengths. Each Film Strip is individually wrapped in a pouch, and is available in an 8 and 16 count package size.

Each Naus-Ease® (Meclizine Hydrochloride), USP Film Strips is green, rectangular shaped, with "S1" printed on each film strip.

NDC Numbers:
Naus-Ease® (Meclizine Hydrochloride), USP;   8 Film Strips: 49467-104-01
Naus-Ease® (Meclizine Hydrochloride), USP; 16 Film Strips: 49467-104-16

Tamper Evident: Each Naus-Ease® (Meclizine Hydrochloride), USP Film Strip is individually sealed in a pouch. Do not use if individual pouch is torn, broken, or shows any signs of tampering.

Note:
Store at controlled room temperature 68-86°F (20-30°C)
Protect from heat and humidity
Use by the expiration date on the package


Terms of Use

http://www.nausease.com is a Sunascen Therapeutics LLC Website

       This site and related services are provided subject to your compliance with the terms and conditions set forth below. Please read the following information carefully. Your continued use of this site will indicate your agreement to be bound by the terms and conditions set forth below. If you do not agree to be bound by the terms and conditions, and our privacy policy, promptly exit this site. Continued use of this site indicates your acceptance of our privacy policy, and terms and conditions. Sunascen Therapeutics LLC, ("Sunascen, or Sunascen Therapeutics") reserves the right to revise the terms described below at any time, without notice to you, by updating this posting. You are bound by any revisions and, therefore, should periodically visit this page to review the current terms that apply to your use the web site.

Restrictions on Use and Ownership
       All web pages within this website and any material made available for download (collectively the Website) are the property of Sunascen Therapeutics LLC (hereinafter termed “Sunascen” or “Sunascen Therapeutics”). The content on the Website is provided for informational purposes only. Sunascen Therapeutics maintains this Website from our offices in Rockville, Maryland, USA. We make no representations that information and materials on our web site are appropriate or available for use in other locations. If you access this site from any location outside of the United States, it shall be done on your own initiative and you will be responsible for compliance with applicable laws at your location.
       Sunascen Therapeutics hereby grants you a nonexclusive authorization to use the Website solely for non-commercial use within the Terms and Conditions identified on this page. You are prohibited to use the Website to obtain data, materials, or said information for the purposes of gaining a competitive advantage. In condition of your use of the Website, you agree to the terms set by Sunascen Therapeutics that you will not use the Website for unlawful purposes or other use prohibited by these Terms and Conditions. Your authorization to use the Website will automatically be terminated upon breaching the Terms and Conditions and you must destroy any downloaded or printed materials immediately. Furthermore, violation of applicable Intellectual Property Laws will give rise to civil and/or criminal penalties.
       The contents found on the Website, including but not limited to images, audio, video, and the text, are copyrighted and are unauthorized to be reproduced, modified, distributed, or used, in part or in whole, without the prior written consent of Sunascen Therapeutics. To prevent a breach of contract you must keep intact all proprietary notices, such as trademarks, copyrights, and other identifying information while complying with any applicable end user license agreements. Any use of these materials on any other Web site or networked computer environment for any purpose is prohibited. You are not authorized to download material from this web site for any purpose without prior written consent.
       Individuals visiting or viewing this website are not authorized to make copies of any of the material for any purpose, with an exception to the automatic copies that your Web browser will make to a temporary cache on your computer’s hard drive.
       All rights reserved by Sunascen Therapeutics LLC.

Procedure for Making Claims of Copyright Infringement
       In accordance with the Digital Millennium Copyright Act (17 U.S.C. § 512), Sunascen Therapeutics makes every effort to be compliant with the United States Copyright Laws. Any notifications of claimed copyright infringement are asked to be brought to the immediate attention of the President of Sunascen Therapeutics. Both paper mail and E-mails sent to the President of Sunascen Therapeutics regarding infringement will be responded to immediately.

Trademark Notice
       Trademarks, text, Website design, graphics, logos, icons, images, as well as the selection, assembly and arrangement thereof, service marks, and slogans displayed on the Website are both registered and unregistered trademarks belonging to and remaining as the sole property of Sunascen Therapeutics, unless otherwise stated. Information contained on the Website is not be construed as a granted license or an authorization to use the trademarks, text, Website design, graphics, logos, icons, images, as well as the selection, assembly and arrangement thereof, service marks, and slogans. Other trademarks, service marks, slogans, and logos used on the Website are trademarks, slogans, service marks, or logos of their respective owners and have been properly referenced. You are not authorized to use, download, upload, copy, print, display, perform, reproduce, republish, license, post, modify, transmit or distribute any information from this Web site in whole or in part without prior written permission from the President of Sunascen Therapeutics LLC. All rights reserved by Sunascen Therapeutics LLC.

Not Medical Advice
       Sunascen Therapeutics is not providing diagnostic medical information, or similar advice through the Website. The information provided is not intended to replace medical judgment or advice offered or obtained by a physician and other qualified healthcare professionals. The information obtained from the Website may be inappropriate for your own situation, or may be misinterpreted. We do not condone use of information provided in this website as diagnostic material nor is the information contained herein suitable diagnosing a health problem or disease. Always consult a physician or other qualified healthcare professional regarding your health concerns. The information on this Website does not provide a warranty or guarantee of any strategy, recommendation, treatment, action, or application of medication. This Website does not provide Medical Advice. By reading this material you have not learned any information to replace the medical judgment of a doctor or a healthcare professional and cannot be considered as a form of medical advice. For advice about your own situation and health, ask your doctor.
       The technologies and some drug products described in this Website are available for sale in interstate commerce based on criteria determined by the United States Food and Drug Administration (FDA). Additionally, some technologies, and drug products are under development and may not be approved by government regulatory authorities. These unapproved products can possibly, be used based on criteria as predetermined by the FDA or in certain experimental clinical trials under the close supervision of a physician. Some products have been approved by the FDA or global regulatory authorities for medical use. It may be best for you to consult your doctor regarding information about those approved products. Sunascen Therapeutics takes no responsibility for how individuals use the information obtained from this Website. Although Sunascen Therapeutics makes every effort to keep information on this Website up to date, medical information changes rapidly, and therefore, some information may be out of date.

Warranty Disclaimer
       The Website, including any content or information contained within it and Website-related service is provided with all faults, and no representations, or warranties of any kind, expressed or implied, including, but not limited to, the implied warranties of merchantability, fitness for a particular purpose, and non-infringement of intellectual property. You assume total responsibility and risk for your use of this site, site-related services, and hyperlinked websites. No oral or written information or advice is given by the Website. Sunascen Therapeutics authorized representatives shall not create a warranty or in any way increase the scope of the warranty discussed. Sunascen Therapeutics, its suppliers, vendors, or other third affiliates will not be considered liable for damages, losses, or events leading to the damages or losses in any event arising directly or indirectly from the use of, inability to use, or the results of use of this Website.
       Furthermore, Sunascen Therapeutics does not warrant the timeliness of the materials, accuracy, or completeness of this Website. It makes no representations or warranties, express or implied, with respect to any information obtained through the Website.
       Sunascen Therapeutics reserves the right to make changes to the materials and information provided on the Website at any time without notice. If the materials and information on the Website are out of date Sunascen Therapeutics makes no commitment to update the materials or information on this Website. Sunascen Therapeutics does not control, and will not be responsible for any of third-party link sites or their content. Therefore, Sunascen Therapeutics does not endorse, provide information for, represent products or material, or authorize representation of Sunascen Therapeutics content on their sites unless otherwise stated. Accessing third-party sites linked from this site is done entirely at your own risk. Sunascen Therapeutics, its suppliers, or other third parties mentioned at this site will not be liable for any damages or losses arising directly or indirectly from the use of third party sites.

Limitation of Liability
       Sunascen Therapeutics, its affiliates, suppliers, and third parties mentioned on the Website are nether responsible nor liable for any direct, indirect, incidental, consequential, exemplary, punitive, special, or other damages whatsoever (including, without limitation, those resulting from lost data, lost profits, or business interruption) relating to or arising from the Website, Website-related services, products, content or information contained within the Website, and/or any hyperlinked website, whether based on warranty, contract, tort, or any other legal theory and whether or not advised of the possibility of such damages. If you are dissatisfied with the Website, Website-related services, and/or hyperlinked websites to third parties, we advise you to stop using the Website and services. Applicable law may not allow the exclusion or limitation of incidental or consequential damages, so the above limitation or exclusion may not apply to you.

Accuracy and Integrity of Information
       Although Sunascen Therapeutics makes every attempts to ensure the integrity and accuracy of the Website, it makes no guarantees whatsoever as to the correctness or accuracy of the Website. It may be possible that the Website could include typographical errors, inaccuracies, and other errors, where unauthorized additions, deletions and alterations could be made to the Website by third parties. In the event of an inaccuracy, please contact us with details regarding the errors so that it can be corrected. Information contained on the Website may be changed or updated without notice.

Confidential and Proprietary Information / Visitor Submissions
       Sunascen Therapeutics does not want to receive confidential or proprietary information from you through the Website or via email unless authorized by a secure link. Please note that any information or material sent to Sunascen Therapeutics through the Website or by other means including e-mail or the US mail, including e-mail and all data, images, sounds, text, and other things embodied therein, (collectively "Communication") will only be considered confidential based on Health Insurance Portability and Accountability Act of 1996. Sending Sunascen Therapeutics any Communication, you grant Sunascen Therapeutics unrestricted, irrevocable, royalty free license to use, reproduce, display, modify, transmit, perform, and distribute in and on all forms of media now known or later developed world-wide unless such information is prohibited by local state or federal laws, such as the Health Insurance Portability and Accountability Act of 1996. You also agree that Sunascen Therapeutics is free to use any ideas, concepts, know-how, or techniques that you send us for any purpose.

Hyperlinks to this Site
       Those persons constructing other websites may link to any of the pages on this Website, only after gaining written permission from the President of Sunascen Therapeutics. However, you are prohibited to copy any of the materials from this Website onto your own web server for any reason. You are prohibited to link isolated elements on this Website (including photographs, illustrations, diagrams, buttons, text, or any other elements in any way) for the purpose of "inlining" or linking said elements into the context of other Web pages. In laymen’s terms, a link to entire pages on this website is acceptable; however links to specific pictures or parts are unacceptable. Misuse or other use will be a violation of copyright and could subject you to legal action.

Caching
       Web mirror sites, and commercial online services, may request written permission to cache entire Websites to their hard disc to allow people to access the Website more easily, or rapidly. Under no circumstances will they be granted the right to copy parts of this Website, the entire Website piecemeal preserving all links, and not using any material out of the original context. Please send an e-mail to info@sunascen.com describing your request for permission to "mirror" the Website.

Web Site Availability
       The Website may be unavailable on occasions due to updating, construction, or failures such as technical, software, mechanical, hardware, or third-party vendor failures. Sunascen Therapeutics is unable to predict or control when these downtimes may occur, or the duration of downtime.

Choice of Law and Venue
       These Terms and Conditions are entered into the State of Maryland, and the State of Delaware and are governed by and construed in accordance with State of Maryland and/or the State of Delaware laws. All parties to these Terms and Conditions agree to the exclusive jurisdiction of the state and federal courts in the State of Maryland and/or the State of Delaware, and therefore waive any jurisdictional, venue, or inconvenient forum objections to such courts. In any action to enforce these Terms and Conditions, the costs and attorney’s fees will be entitled to prevailing party. In the event that any of the Terms and Conditions are held by a court or other tribunal of competent jurisdiction to be unenforceable, such provisions shall be limited or eliminated to the minimum extent necessary so that these Terms and Conditions shall otherwise remain in full force and effect.

Entire Agreement
       The Terms and Conditions constitute the entire agreement between Sunascen Therapeutics and you pertaining to the subject matter hereof. Sunascen Therapeutics, in its sole discretion may at any time revise these Terms and Conditions by updating this posting. Therefore, you are encouraged to periodically visit this page to review the current Terms and Conditions, so that you are aware of any such revisions to which you are bound. Provisions of these Terms and Conditions may be superseded by expressly designated legal notices or terms located on particular pages within this Website.



Privacy Policy

http://www.nausease.com is a Sunascen Therapeutics LLC Website

        Sunascen Therapeutics LLC, ("Sunascen, or Sunascen Therapeutics") understands and recognizes the importance of protecting the privacy of identifiable information we may obtain from visitors to our web site. You are encouraged to visit our web site without telling us anything about yourself. Although, we keep track of the total number of visitors to our website, the number of visitors to each page of the website, and the domain names of our visitors’ Internet service providers, we do not gather personally identifiable information in this process. If you choose to contact us and choose to provide personally identifiable information, we will only utilize the information to respond to your inquiry, and for regulatory compliance. We do not collect or maintain personally identifiable information for resale purposes, or share your information with any other company or organization unless required for regulatory compliance. Any and all uses comply with applicable laws.
       Sunascen Therapeutics does not want to receive confidential or proprietary information from you through the Website or via email. Please note that any information or material sent to Sunascen Therapeutics through the Website or by all means including e-mail or the US mail, including e-mail and all data, images, sounds, text, and other things embodied therein, (collectively "Communication") will be considered not confidential, unless otherwise stated or as applicable to state and federal law. Sending Sunascen Therapeutics any Communication, you grant Sunascen Therapeutics unrestricted, irrevocable, royalty free license to use, reproduce, display, modify, transmit, perform, and distribute in and on all forms of media now known or later developed world-wide unless such information is prohibited by local, state, or federal laws, such as the Health Insurance Portability and Accountability Act of 1996. You also agree that Sunascen Therapeutics is free to use any ideas, concepts, know-how, or techniques that you send us for any purpose, unless otherwise agreed upon and documented by both parties.

Personally Identifiable Information
        Sunascen Therapeutics collects personally identifiable information, such as names, e-mail addresses and the like, addresses, only when they are voluntarily provided by a web site visitor. We will notify you as to the uses, if any, we intend to make of that information beyond responding to your inquiry or for regulatory compliance. We will not use your personal information for any other purpose, unless previously specified

Children
        You should be aware that this web site is not intended for, or designed to attract, children under the age of 13. As noted above, we do not collect personally identifiable information - including an individual’s age unless voluntarily provided by a web site visitor for regulatory compliance.

Links to Other Sites
        Links to third-party Websites found on this site are provided as a convenience to you. If you use these links, you will leave this site. Sunascen Therapeutics does not control nor will it be responsible for any of these third-party link sites or their content. Thus, Sunascen Therapeutics does not endorse or take any representations about them, or any information or product or material found in them. If you decide to access any of the third-party sites linked to this site, you do so entirely at your own risk.

Unsecured Email Warning
        Please note that any information you send to Sunascen Therapeutics via email is sent via an unsecured email link. Due to the nature of the Internet, there remains a possibility that unsecured or unencrypted email could be intercepted and read by third parties. Sunascen Therapeutics assumes no responsibility for interception of confidential information you send in an unsecured or unencrypted email message.

Changes
        Any changes to this privacy policy will be communicated on this page. You are encouraged to return to check the privacy policy for the latest updates prior to sending us any personally identifiable information.

Contact Us
        If you have any questions about this privacy statement, the practices of this web site, or your dealings with this web site, please contact us at info@sunascen.com.